Asia Cup final: India beat Malaysia 2-1 to win third Asia Cup title

Agencies
October 22, 2017

Dhaka, Oct 23: India on Sunday ended their 10-year wait for continental triumph when they beat a gutsy Malaysia 2-1 in a nail-biting final to clinch their third Asia Cup hockey title.

India, which won the Asia Cup last time in 2007 in Chennai, scored from field efforts through Ramandeep Singh (3rd minute) and Lalit Upadhyay (29th) to dash Malaysian hopes. Malaysia were in summit clash for the first time since tournament's inception.

The ever-improving Malaysians, however, fought valiantly and didn't give up for a single minute. Their efforts bore fruit in the 50th minute when Shahril Saabah pulled one goal back.

The Indians, ranked sixth in the world, were in for nervous last 10 minutes but the defence did enough to hold on to the lead.

Pakistan won the bronze medal after edging out Korea 6-3 in the third-fourth place play-off match earlier in the day.

For India' new chief coach Marijne Sjoerd, it was perfect start to his stint as the Asia Cup was his maiden tournament in charge of the senior national side.

The top-ranked Indians finished unbeaten in the tournament, having won all their matches except for the 1-1 draw against Korea in the Super 4s stage.

Today's win was India's second victory over Malaysia in the tournament, having beaten them 6-2 in the Super 4s stage.

For Malaysia, it was their best result in the tournament. They had earlier won the bronze in the 2007 edition of the event in Chennai.

The Indians came out all guns blazing and took the lead as early as the third minute through Ramandeep, who scored from a rebound after his initial deflection from SV Sunil's cross hit the post.

Chinglensana Singh's reverse hit from close range then went wide as India wasted a golden chance.

It was a battle fought on even keel between the two teams as Malaysia secured their first penalty corner in the 13th minute but wasted it.

Harmanpreet Singh was then denied by Razie Rahim as he made a goalline save to keep out the Indian defender's flick from India's first penalty corner.

Minutes later Malaysian goalkeeper Kumar Subramaniam made double save -- first kept out Akashdeep Sinh's shot and then denied Amit Rohidas from the resultant set piece.

A minute before the half time, Lalit doubled India's lead when he beautifully deflected home Sumit's reverse hit cross from the left flank.

After the change of ends, Lalit and Ramandeep came tantalisingly close to extending India's tally of goals but their shots from inside the D were off target.

Down by two goals, the Malaysians came out all guns blazing in the fourth and final quarter in search of the equaliser and gave the Indian defence a run for their money.

After wasting their second penalty corner, Malaysia came back into the match when Saabah scored from close range in the 50th minute as the Young Indian defence wilted under pressure for a second.

It was nervous last 10 minutes for the Indians as Malaysia mounted attack after attack in search of an equaliser.

In the form of their third penalty corner, Malaysia had a golden opportunity to take the match into shoot-out but the Indian defence stood tall to maintain their slender lead.

With three minutes from the hooter, Malaysia withdrew goalkeeper Subramaniam for an extra player but the move failed to yield desired result as the Indians managed to hold on to their lead for a famous victory.

Comments

ahmed
 - 
Monday, 23 Oct 2017

Alhamdhulillah ...By the grace of Allah Swt  Indian Hockey team won the cup...Great achivement by Indian hockey players ...with team work...

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 26,2020

Feb 26: In his first reaction to incidents of violence in Delhi which have left at least 20 people dead, Prime Minister Narendra Modi on Wednesday appealed for peace and brotherhood, and said he has held an extensive review of the prevailing situation in various parts of the national capital.

He also said it was important that calm and normalcy was restored at the earliest.

“Had an extensive review on the situation prevailing in various parts of Delhi. Police and other agencies are working on the ground to ensure peace and normalcy,” Modi tweeted.

Stressing that peace and harmony are “central to our ethos”, Modi said, “I appeal to my sisters and brothers of Delhi to maintain peace and brotherhood at all times.”

At least 20 people have been killed since Sunday in communal violence in Northeast Delhi, triggered after clashes between pro and anti-CAA protestors over the Citizenship (Amendment) Act.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 19,2020

New Delhi, Jun 19: Delhi minister Satyendar Jain's health has deteriorated further. He is infected with the coronavirus. Jain has also been diagnosed with pneumonia. He is being shifted to an ICU.  According to doctors, Jain is now kept full-time on oxygen support as his oxygen saturation level has dipped.  

Jain was admitted to Rajiv Gandhi Super Speciality Hospital early Tuesday after running high fever and suffering a sudden drop in oxygen level. The 55-year-old leader's test result came positive on Wednesday evening after a second test. Jain was brought to the hospital and was administered a test for the novel coronavirus infection on Tuesday morning, for which he tested negative. But he still ran fever and showed symptoms, so another test was done after 24 hours of the first.

He will now be shifted Max Hospital in Saket and administered plasma therapy. 

Union Home Minister Amit Shah has also wished for Jain's speedy recovery.

On Thursday, Delhi Deputy Chief Minister Manish Sisodia took over the charge of health, PWD, power and other departments held by Jain. Jain will remain the cabinet minister without any portfolio in the Arvind Kejriwal government until he recovers. 

On Sunday, Jain attended a high-level meeting on the coronavirus situation in the national capital, chaired by Union Home Minister Amit Shah, which was also attended by Delhi Lt Governor Anil Baijal, Kejriwal, Sisodia and Union Health Minister Harsh Vardhan.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.